Not all fat is equal. Visceral fat surrounds your organs and poses serious health risks, while subcutaneous fat is less harmful. Here's how to reduce both.

A new analysis from the PALOMA-2 study shows that subcutaneous administration of amivantamab every four weeks (Q4W), in ...

A new analysis from the PALOMA-2 study presented today shows that subcutaneous administration of amivantamab every four weeks (Q4W), in combination with daily oral lazertinib, yields a high objective ...